Ordinary Adjustment | Solactive Blockbuster Biotech Drugs Index | Effective Date 19th February 2026
Solactive Blockbuster Biotech Drugs Index:
In the ordinary adjustment, the following composition will be implemented effective open 19th February 2026:
| ABBVIE INC |
| ALNYLAM PHARMACEUTICALS INC |
| AMGEN INC |
| ARGENX SE – ADR |
| ASCENDIS PHARMA A/S |
| BEONE MEDICINES LTD-ADR |
| BIOGEN INC |
| BIOMARIN PHARMACEUTICAL INC |
| BRISTOL-MYERS SQUIBB CO |
| ELI LILLY & CO |
| GENMAB A/S |
| GERON CORP |
| GILEAD SCIENCES INC |
| GSK PLC-SPON ADR |
| IMMUNITYBIO INC |
| JOHNSON & JOHNSON |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC CLASS A |
| KRYSTAL BIOTECH INC |
| MERCK & CO. INC. |
| MODERNA INC |
| NOVARTIS AG-SPONSORED ADR |
| NOVO-NORDISK A/S-SPONS ADR |
| PFIZER INC |
| REGENERON PHARMACEUTICALS |
| RHYTHM PHARMACEUTICALS INC |
| SANOFI-ADR |
| SUMMIT THERAPEUTICS PLC |
| TAKEDA PHARM-ADR |
| TG THERAPEUTICS INC |
| VERTEX PHARMACEUTICALS INC |